BOSTON, July 1, 2024
/PRNewswire/ -- Neuroglee Health, a leading cognitive care
solutions company, announced today that it was selected to
support patients and caregivers in the Center for Medicare and
Medicaid Innovation's (CMMI's) Guiding an Improved Dementia
Experience (GUIDE) Model, a new, 8-year program that aims to
transform how care for Alzheimer's disease and related dementias is
delivered, coordinated and reimbursed.
In conjunction with its acceptance into the GUIDE program, the
company also announced in June during Alzheimer's and Brain
Awareness month that it has evolved its name from Neuroglee
Therapeutics to Neuroglee Health. The new name reflects the
company's strategic expansion of its evidenced-based, clinically
proven technology solution, Neuroglee Connect™, with a
physician-led interdisciplinary care team focused on optimizing
value-based outcomes for patients with mild cognitive impairment
(MCI) through dementia.
"We are honored to be selected as a participant in this exciting
new program," said Neuroglee Health Founder and CEO Aniket Singh
Rajput. "Our acceptance is another strong validation of our model
and will accelerate our ability to deliver best-in-class outcomes
for patients and their care partners throughout the disease
journey."
Neuroglee's GUIDE acceptance was driven by its comprehensive
cognitive care approach that includes a clinically validated
solution for "entry point" patients with MCI, in addition to its
dementia care model that will support patients in the CMMI
program.
"By going upstream to identify and engage patients with a proven
solution for MCI, we are able to more effectively manage the health
of this complex population," added Rajput. "We are also able to
build longitudinal relationships with patients and care partners to
enhance engagement and outcomes in powerful new ways."
Neuroglee Health's acceptance to GUIDE can also help solve
critical challenges for primary care organizations and payors who
are faced with managing this rapidly growing, high-cost population.
By serving as their virtual cognitive care team extension,
Neuroglee Health enables its partners to offer patients and care
partners immediate access to evidence-based cognitive care
solutions at the earliest indicators of cognitive decline through
dementia.
"As demonstrated by the GUIDE Model, we are seeing a paradigm
shift occurring in the payor community embracing the need to better
support patients with dementia," said Neuroglee Health Senior Vice
President Michael Lubin. "We are
excited to be at the forefront of this evolution offering new care
options that can transform the lives of families living with
dementia from the comfort of their homes."
About Neuroglee Health
Neuroglee Health is on a mission to disrupt the cognitive care
status quo. Neuroglee Health partners with providers and health
plans to serve as their virtual cognitive care extension to support
patients and care partners from early cognitive decline through
late-stage dementia. Neuroglee Health delivers immediate access to
its evidenced-based, clinically proven, tech-enabled solution
supported by an expert, physician led, interdisciplinary care team
that slow disease progression, enhance quality of life, prolong
independence, and reduce avoidable costs. To learn more about
how Neuroglee Health is disrupting cognitive care, visit
www.neuroglee.com
Media Contact
Tara
Stultz
Amendola Communications for Neuroglee
440-225-9595
tstultz@acmarketingpr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neuroglee-health-selected-for-cms-guide-model-program-and-announces-company-name-evolution-302186989.html
SOURCE Neuroglee Health